Amarin Corp Plcuk (AMRN) Operating Income (QoQ) (2010 - 2026)

Amarin Corp Plcuk (AMRN) Operating Income (QoQ) (2010 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -132.54%
Dec 31, 2025 413.73%
Sep 30, 2025 30.54%
Jun 30, 2025 4.60%
Mar 31, 2025 -183.88%
Dec 31, 2024 179.37%
Sep 30, 2024 -4,703.05%
Jun 30, 2024 96.14%
Mar 31, 2024 -127.53%
Dec 31, 2023 329.98%
Sep 30, 2023 10.47%
Jun 30, 2023 -38.16%
Mar 31, 2023 -80.90%
Dec 31, 2022 -86.35%
Sep 30, 2022 91.81%
Jun 30, 2022 -121.97%
Mar 31, 2022 -434.84%
Dec 31, 2021 164.67%
Sep 30, 2021 -249.01%
Jun 30, 2021 759.13%